Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 306

Similar articles for PubMed (Select 19384265)

1.

The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability.

Lea R, Colson N, Quinlan S, Macmillan J, Griffiths L.

Pharmacogenet Genomics. 2009 Jun;19(6):422-8. doi: 10.1097/FPC.0b013e32832af5a3.

PMID:
19384265
2.

Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation.

Menon S, Lea RA, Roy B, Hanna M, Wee S, Haupt LM, Oliver C, Griffiths LR.

Pharmacogenet Genomics. 2012 Oct;22(10):741-9. doi: 10.1097/FPC.0b013e3283576b6b.

PMID:
22926161
4.

Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.

Nakhoul F, Abassi Z, Plawner M, Khankin E, Ramadan R, Lanir N, Brenner B, Green J.

Isr Med Assoc J. 2004 Apr;6(4):213-7.

5.

Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.

Ho GY, Eikelboom JW, Hankey GJ, Wong CR, Tan SL, Chan JB, Chen CP.

Stroke. 2006 Feb;37(2):456-60. Epub 2006 Jan 5.

6.

[Lowering high levels of fasting total homocysteine with folic acid and vitamins B in patients with venous thromboembolism: relationship between response and the C677T methylenetetrahydrofolate reductase (MTHRF) genotype].

González Ordóñez AJ, Medina Rodríguez JM, Fernández Alvarez CR, Sánchez García J, Fernández Carreira JM, Alvarez Martínez MV, Coto García E.

Med Clin (Barc). 2000 Jan 15;114(1):7-12. Spanish.

PMID:
10782453
7.

Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes.

Pastore A, De Angelis S, Casciani S, Ruggia R, Di Giovamberardino G, Noce A, Splendiani G, Cortese C, Federici G, Dessi' M.

Clin Chem. 2006 Jan;52(1):145-8.

8.

Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.

Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E; Heart Outcomes Prevention Evaluation 2 Investigators.

Stroke. 2009 Apr;40(4):1365-72. doi: 10.1161/STROKEAHA.108.529503. Epub 2009 Feb 19.

9.

Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.

Lee BJ, Huang MC, Chung LJ, Cheng CH, Lin KL, Su KH, Huang YC.

Eur J Clin Nutr. 2004 Mar;58(3):481-7.

PMID:
14985687
11.

[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].

Sánchez Alvarez JE, Pérez Tamajón L, Hernández D, Alvarez González A, Delgado P, Lorenzo V.

Nefrologia. 2005;25(3):288-96. Spanish.

PMID:
16053010
12.

Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.

Bleie Ø, Semb AG, Grundt H, Nordrehaug JE, Vollset SE, Ueland PM, Nilsen DW, Bakken AM, Refsum H, Nygård OK.

J Intern Med. 2007 Aug;262(2):244-53.

PMID:
17645592
13.

Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.

Nanayakkara PW, Kiefte-de Jong JC, ter Wee PM, Stehouwer CD, van Ittersum FJ, Olthof MR, Teerlink T, Twisk JW, van Guldener C, Smulders YM.

Am J Kidney Dis. 2009 Jan;53(1):41-50. doi: 10.1053/j.ajkd.2008.06.016. Epub 2008 Sep 11.

PMID:
18786751
14.

Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients.

Marcucci R, Zanazzi M, Bertoni E, Rosati A, Fedi S, Lenti M, Prisco D, Castellani S, Abbate R, Salvadori M.

Transplantation. 2003 May 15;75(9):1551-5.

PMID:
12792513
15.

The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study.

Strandhagen E, Zetterberg H, Aires N, Palmér M, Rymo L, Blennow K, Landaas S, Thelle DS.

Int J Mol Med. 2004 Jun;13(6):811-5.

PMID:
15138617
16.

The association between atopy and factors influencing folate metabolism: is low folate status causally related to the development of atopy?

Husemoen LL, Toft U, Fenger M, Jørgensen T, Johansen N, Linneberg A.

Int J Epidemiol. 2006 Aug;35(4):954-61. Epub 2006 Jun 9.

17.

Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention.

Bleie Ø, Refsum H, Ueland PM, Vollset SE, Guttormsen AB, Nexo E, Schneede J, Nordrehaug JE, Nygård O.

Am J Clin Nutr. 2004 Sep;80(3):641-8.

18.

Influence of MTHFR genotype on contingent negative variation and MRI abnormalities in migraine.

de Tommaso M, Difruscolo O, Sardaro M, Losito L, Serpino C, Pietrapertosa A, Santeramo MT, Dicuonzo F, Carella A, Lamberti P, Livrea P.

Headache. 2007 Feb;47(2):253-65.

PMID:
17300365
19.

The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism.

Hustad S, Midttun Ø, Schneede J, Vollset SE, Grotmol T, Ueland PM.

Am J Hum Genet. 2007 May;80(5):846-55. Epub 2007 Mar 13.

20.

Assessment of tailor-made prevention of atherosclerosis with folic acid supplementation: randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype.

Miyaki K, Murata M, Kikuchi H, Takei I, Nakayama T, Watanabe K, Omae K.

J Hum Genet. 2005;50(5):241-8. Epub 2005 May 14.

PMID:
15895286
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk